Artificial Intelligence and Respiratory Diagnostics

ARTIFICIAL INTELLIGENCE AND RESPIRATORY DIAGNOSTICS:

FROM SPIROMETRY TO THE “DIGITAL STETHOSCOPE”

In recent years, artificial intelligence (AI) has begun to profoundly transform medicine. Pulmonology is also undergoing a true revolution, with the development of systems capable of analyzing respiratory signals, images, and clinical data to diagnose and monitor lung diseases.

Among the most promising innovations are multimodal deep learning models, capable of integrating various sources of information—such as respiratory sounds and spirometric data—to recognize conditions like asthma and chronic obstructive pulmonary disease (COPD) with high accuracy.

From Traditional Diagnosis to Digital Models

The diagnosis of respiratory diseases traditionally relies on:

· medical history and symptoms

· physical examination (auscultation)

· spirometry

· chest imaging

While these tools are essential, they have certain limitations:

· dependence on the clinician’s experience

· inter-observer variability

· limited access in certain regions

· often delayed diagnosis

Artificial intelligence aims to overcome these limitations by introducing objective, reproducible, and scalable tools.

How AI works in respiratory diagnosis

New AI systems use machine learning and deep learning algorithms to analyze large amounts of data.

In the case of respiratory diseases, the main data sources include:

1. Acoustic signals

Recordings of:

· cough

· breathing

· rales and wheezes

These signals are analyzed to identify patterns characteristic of different diseases.

2. Spirometric data

Flow-volume curves and other respiratory parameters are automatically interpreted, identifying even subtle abnormalities.

3. Clinical and environmental data

Information on:

· symptoms

· medical history

· environmental exposures

is integrated to improve diagnostic accuracy.

Accuracy and performance

Recent studies show that AI models can achieve:

· accuracies exceeding 90% in the diagnosis of asthma and COPD

· high sensitivity in identifying early changes

· the ability to distinguish between different respiratory conditions

These results are particularly significant because they point to the possibility of early, automated diagnosis.

Interpretability: a step forward from the past

One of the most innovative aspects of recent models is their interpretability.

Techniques such as:

· Grad-CAM

· SHAP (Shapley Additive Explanations)

allow us to understand:

· which signal features influenced the diagnosis

· which regions of the image or signal are most relevant

This represents a fundamental element for the integration of AI into clinical practice.

Clinical Applications

Artificial intelligence can be used in various contexts:

Early Screening

Identification of at-risk patients before the onset of obvious symptoms.

Diagnostic Support

Assistance for clinicians in diagnosis, especially in settings with limited specialist expertise.

Telemedicine

Remote patient monitoring, with data collection via wearable devices or smartphones.

Community medicine

The ability to use diagnostic tools even outside the hospital.

Toward a “digital stethoscope”

One of the most fascinating applications is the transformation of the stethoscope into an advanced digital tool.

The new devices can:

· record respiratory sounds

· analyze them in real time

· provide immediate diagnostic support

In practice, the physician can have an “intelligent stethoscope” capable of integrating clinical experience and algorithmic analysis.

Limitations and challenges

Despite its great potential, the use of AI in pulmonology presents some critical issues:

· need for large-scale clinical validation

· integration into clinical workflows

· data management and privacy

· risk of bias in datasets

Furthermore, AI does not replace the clinician but should be viewed as a decision-support tool.

Implications for pulmonology

The introduction of artificial intelligence marks a profound shift:

From late diagnosis → early diagnosis

From a subjective approach → objective analysis

From hospital-based medicine → community-based medicine

This paves the way for a pulmonology that is:

· more accessible

· more accurate

· more personalized

Artificial intelligence represents one of the most promising innovations in respiratory medicine. However, its true impact will depend not only on technical performance but on the ability to integrate these tools into daily clinical practice.

The future will not be “AI versus the doctor,” but “AI alongside the doctor.”

AI is transforming the diagnosis of respiratory diseases, offering tools capable of early identification of conditions such as asthma and COPD.

The combination of technology, data, and clinical practice could mark the beginning of a new era in pulmonology, where diagnosis is faster, more accurate, and more accessible.